Published in Emerg Infect Dis on March 01, 2014
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res (2014) 3.43
Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. Biomed Res Int (2015) 1.43
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. MBio (2015) 0.88
Molecular Diagnosis of Hemorrhagic Fever with Renal Syndrome Caused by Puumala Virus. J Clin Microbiol (2016) 0.80
Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc. PLoS Pathog (2016) 0.76
Anthropogenically driven environmental changes shift the ecological dynamics of hemorrhagic fever with renal syndrome. PLoS Pathog (2017) 0.75
Extracorporeal membrane oxygenation for the treatment of severe refractory hantavirus cardiopulmonary syndrome. CMAJ (2016) 0.75
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol (1995) 5.30
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Outbreak of acute illness--southwestern United States, 1993. MMWR Morb Mortal Wkly Rep (1993) 1.97
The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg (2000) 1.81
Hantavirus pulmonary syndrome--United States: updated recommendations for risk reduction. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 1.77
Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med (1998) 1.76
Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis (1996) 1.50
Hantavirus pulmonary syndrome, United States, 1993-2009. Emerg Infect Dis (2011) 1.48
Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis (1995) 1.45
Cluster of cases of hantavirus pulmonary syndrome in Alberta, Canada. Am J Trop Med Hyg (2007) 0.95
Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis (1999) 0.90
Domestically acquired seoul virus causing hemorrhagic fever with renal syndrome-Maryland, 2008. Clin Infect Dis (2009) 0.90
Occupational risk of exposure to rodent-borne hantavirus at US forest service facilities in California. Am J Trop Med Hyg (2008) 0.88
Update: outbreak of hantavirus infection--southwestern United States, 1993. MMWR Morb Mortal Wkly Rep (1993) 0.86
Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis (1999) 0.85
Sin nombre hantavirus disease in a ten-year-old boy and his mother. Pediatr Infect Dis J (2000) 0.78
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis (2007) 6.46
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol (2004) 5.86
Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74
Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Coding of facial expressions of pain in the laboratory mouse. Nat Methods (2010) 4.47
A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med (2012) 4.15
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Marburg virus infection detected in a common African bat. PLoS One (2007) 4.01
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87
Salmonellosis outcomes differ substantially by serotype. J Infect Dis (2008) 3.77
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis (2007) 3.74
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology (2011) 3.70
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
Discovery of swine as a host for the Reston ebolavirus. Science (2009) 3.68
West Nile virus in California. Emerg Infect Dis (2004) 3.66
Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis (2006) 3.65
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Rift Valley fever virus. J Am Vet Med Assoc (2009) 3.22
Measles outbreak--California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep (2015) 3.20
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 3.04
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis (2002) 2.89
Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis (2005) 2.85
Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis (2009) 2.82
Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol (2003) 2.75
Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis (2009) 2.73
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis (2008) 2.72
Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Responsibilities of veterinarians on issues of antimicrobial resistance. J Am Vet Med Assoc (2010) 2.67
Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis (2005) 2.62
Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis (2003) 2.61
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis (2002) 2.50
Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems. Clin Infect Dis (2012) 2.45
Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection. Clin Infect Dis (2006) 2.41
Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol (2006) 2.39
A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis (2011) 2.37
Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36
A mouse atlas of gene expression: large-scale digital gene-expression profiles from precisely defined developing C57BL/6J mouse tissues and cells. Proc Natl Acad Sci U S A (2005) 2.35
New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol (2002) 2.35
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33
Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology (2005) 2.25
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis (2003) 2.22
Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis (2010) 2.22
Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res (2007) 2.21
Consumer attitudes and use of antibiotics. Emerg Infect Dis (2003) 2.20
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog (2010) 2.18
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother (2008) 2.14
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis (2004) 2.07
Successful topical respiratory tract immunization of primates against Ebola virus. J Virol (2007) 2.06
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Clin Infect Dis (2005) 2.01
Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis (2010) 2.00
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00